http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA06012175-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2278 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate | 2005-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6b7e80272e8680a1fe4720b10ef435c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_940ca3e9c6707a42c9d3c328b6c49a56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45bcf837e1d3084441e07138deb199ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eb33d850743c32e0f3a505580b38114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba53ed39128604c53b9ecd741e0090f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d382a01cbb4d4d35b2c3680185f9ee9b |
| publicationDate | 2007-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-PA06012175-A |
| titleOfInvention | PROMOTER OF CORNEAL NEURITOGENESIS CONTAINING POLYPEPTIDE ACTIVATOR OF THE CYCLASS ADENYLATE OF THE PITUITARY AND ITS DERIVATIVES. |
| abstract | The present invention describes an agent to promote corneal neuritogenesis containing PACAP, a derivative of PACAP or a pharmaceutically acceptable salt thereof, in particular, an agent to promote corneal neuritogenesis indicated in the improvement of corneal sensitivity, dry eye treatment and treatment of corneal epithelial lesion due to a promoter effect of corneal neuritogenesis; This agent to promote corneal neuritogenesis is used as a drug to relieve the reduction in corneal sensitivity after corneal surgeries, such as laser keratonomy (LASIK) and corneal graft or cataract surgery, reduction in corneal sensitivity that accompanies neurodegeneration corneal and dry eye symptom and corneal epithelial lesion that accompanies such a reduction in corneal sensitivity; however, it is useful as a drug to relieve dry eye symptom, reduction in corneal sensitivity and corneal epithelial injury in patients with dry eye, and a drug to relieve corneal injury and dry eye symptom and reduction in corneal sensitivity that accompanies these. |
| priorityDate | 2004-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 314.